RxDoctor Payments DataLook up a doctor →

Keenan Al-Hojerry, MD

Family Medicine · Portsmouth, NHNPI 1063468981

Payments from drug & device makers

$11,161in general payments, 2019–2025

Across 706 payments — averaging $15.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • AstraZeneca$2K
  • Pfizer$1K
  • Novo Nordisk$925
  • Boehringer Ingelheim$719
  • GSK$484
  • plus $4K from 42 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)178$2,042
AstraZeneca97$1,838
Pfizer82$1,158
Novo Nordisk57$925
Boehringer Ingelheim43$719
GSK22$484
Lilly USA, LLC33$456
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC21$345
Axsome Therapeutics, Inc.17$330
Merck17$303
Takeda Pharmaceuticals U.S.A., Inc.14$260
Johnson & Johnson15$250
Novartis13$201
E.r. Squibb & Sons, L.L.C.12$183
Galderma Laboratories, L.p.2$158
Amarin Pharma, Inc.8$147
Otsuka America Pharmaceutical, Inc.7$121
Abbott6$110
Lundbeck LLC5$95
Astellas Pharma US Inc5$92
Exact Sciences5$87
Janssen Scientific Affairs, LLC3$84
Collegium Pharmaceutical, Inc.5$82
Eisai Inc.5$74
Bayer3$58
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)3$54
Kowa Pharmaceuticals America, Inc.3$52
Baxter Healthcare1$39
Shield Therapeutics Inc2$38
Biohaven Pharmaceutical Holding Company Ltd.2$37
Medicomp Inc1$32
Phathom Pharmaceuticals, Inc.2$31
Shire North American Group Inc2$26
Amgen1$26
Scilex Pharmaceuticals Inc.1$20
Ultragenyx Pharmaceutical Inc.1$20
CSL Behring1$19
Circassia Inc.1$19
Genentech USA, Inc.1$18
Esperion Therapeutics, Inc.1$17
Halozyme Inc1$17
Cequr Corporation1$16
Sanofi-aventis U.S. LLC1$15
Verona Pharma, Inc.1$14
Kaleo, Inc.1$13
Radius Health, Inc.1$12
Teva Pharmaceuticals USA, Inc.1$12
AMAG Pharmaceuticals, Inc.1$12

How this compares

$11,161 in reported general payments places this provider in the 95th percentile of 397 family medicine providers in New Hampshire.

See all family medicine providers in New Hampshire →

Medicare billing

Part B allowed, 2024
$202,573
Medicare patients
610
Services billed
1,980

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Portsmouth

See the full list for New Hampshire →

Where these figures come from

Is this you, or does something look wrong? →